Why the study?
While transcatheter mitral valve replacement offers greater and more reliable reduction in mitral regurgitation than repair, potential disadvantages remain, warranting an assessment of current devices, clinical trial data, and future research directions.
This review highlights that while TMVR provides more reliable reduction in mitral regurgitation than TMVr, it also carries potential disadvantages.
TMVR may suit select patients needing reliable MR reduction despite drawbacks; leaves open randomized head-to-head trials for practice guidance.
) over transcatheter repair is the greater and more reliable reduction in mitral regurgitation. However, there are also potential disadvantages. This review introduces the newest TMVr and TMVR devices and presents clinical trial data to identify current challenges and directions for future research.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: